secwatch.observer — SEC 8-K summary
======================================

Issuer:     STANDARD BIOTOOLS INC. (LAB)
CIK:        0001162194
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001162194-23-000033
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Standard BioTools shareholders approve 4.7M share equity plan increase, elect directors
--------------------------------------------------------------------------------

- Equity plan amendment adding 4,700,000 shares approved with 109.6M votes for (11.4M against).
- Class I directors Michael Egholm and Fenel Eloi elected; B-1/B-2 directors Casdin and Madaus elected.
- Advisory say-on-pay vote passed (99.7M for, 21.3M against); board adopts annual frequency.
- PricewaterhouseCoopers ratified as auditor with 139.3M votes for, 233k against.
- Approximately 90.7% of 153.8M total votes were present at the annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1162194/000116219423000033/0001162194-23-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1162194/000116219423000033/lab-20230614.htm
  HTML page:      https://secwatch.observer/filing/0001162194-23-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer